ZARONTIN Side Effects

7013442-5 | Back Pain
on Sep 01, 2010 Male patient from UNITED STATES , child 9 years of age, was diagnosed with petit mal epilepsy and was treated with Zarontin (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?). Zarontin dosage: Unk (2 Or 3 Mg).

6907163-4 | Fatigue, Vitamin B12 Decreased
Patient was taking Zarontin (View Usage). Patient had the following side effects: fatigue, vitamin b12 decreased on Jul 27, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 130.0 lb, was diagnosed with convulsion and. Zarontin dosage: 250 Mg, 3x/day.

6907019-7 | Rash
Adverse event was reported on Aug 08, 2007 by a Female patient taking Zarontin (View Usage) (Dosage: ) was diagnosed with petit mal epilepsy, grand mal convulsion and. Location: UNITED STATES , 43 years of age, After Zarontin was administered, patient had the following side effects: rash (What is rash?). During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), TOPAMAX (View Topamax Review and Topamax Label ), DEPAKOTE (View Depakote Review and Depakote Label ).

6906980-4 | Libido Increased
on Jan 25, 2008 Male patient from UNITED STATES , 43 years of age, was treated with Zarontin (View Usage). Patient experienced the following unwanted or unexpected effects: libido increased. Zarontin dosage: .


6706173-X | Decreased Appetite, Hypoglycaemia
on Apr 23, 2010 Male patient from IRELAND , child 12 years of age, was diagnosed with convulsion and was treated with Zarontin (View Usage). Patient had the following side effects: decreased appetite, hypoglycaemia. Zarontin dosage: 250 Mg, 1x/day In Morning. During the same period patient was treated with EPILIM (Unk) (View Epilim Review and Epilim Label ).

6634798-9 | Body Height Below Normal
Patient was taking Zarontin (View Usage). After Zarontin was administered, patient had the following side effects: body height below normal on Mar 05, 2010 from UNITED KINGDOM Additional patient health information: Female patient , child 6 years of age, . Zarontin dosage: .

6343556-4 | Asthenia, Urinary Incontinence
Adverse event was reported on Aug 27, 2009 by a Female patient taking Zarontin (View Usage) (Dosage: Unk) was diagnosed with epilepsy (What is epilepsy?) and. Location: FRANCE , child 4 years of age, Patient experienced the following unwanted or unexpected effects: asthenia, urinary incontinence (What is urinary incontinence?). During the same period patient was treated with VALPROIC ACID (500 Mg, 1x/day) (View Valproic Acid Review and Valproic Acid Label ).

6275458-6 | Alopecia, Decreased Appetite
on Jul 06, 2009 Female patient from FRANCE , child 9 years of age, was treated with Zarontin (View Usage). Patient had the following side effects: alopecia, decreased appetite. Zarontin dosage: 1 Unk, Unk.

5729277-7 | Flight Of Ideas, Grand Mal Convulsion, Hallucination, Hypersomnia, Lethargy, Oral Intake Reduced, Petit Mal Epilepsy, Trance, Withdrawal Syndrome
on Apr 24, 2008 Female patient from UNITED KINGDOM , 47 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Zarontin (View Usage). After Zarontin was administered, patient had the following side effects: flight of ideas, grand mal convulsion, hallucination, hypersomnia, lethargy, oral intake reduced, petit mal epilepsy, trance, withdrawal syndrome. Zarontin dosage: . During the same period patient was treated with TEGRETOL (View Tegretol Review and Tegretol Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), TETRACYCLINE (View Tetracycline Review and Tetracycline Label ).

5572304-0 | Oral Herpes
Patient was taking Zarontin (View Usage). Patient experienced the following unwanted or unexpected effects: oral herpes on Dec 11, 2007 from ITALY Additional patient health information: Female patient , weighting 28.66 lb, was diagnosed with epilepsy (What is epilepsy?) and. Zarontin dosage: Daily Dose:100mg. During the same period patient was treated with VALPROATE SODIUM (Daily Dose:350mg) (View Valproate Sodium Review and Valproate Sodium Label ). Patient was hospitalized.

5502419-4 | Priapism
Adverse event was reported on Oct 18, 2007 by a Male patient taking Zarontin (View Usage) (Dosage: ) was diagnosed with epilepsy (What is epilepsy?), hiv infection (What is hiv infection?) and. Location: FRANCE , weighting 158.7 lb, Patient had the following side effects: priapism. During the same period patient was treated with DEPAKENE (Daily Dose:2000mg) (View Depakene Review and Depakene Label ), COMBIVIR (View Combivir Review and Combivir Label ), VIRAMUNE (View Viramune Review and Viramune Label ). Patient was hospitalized.

5406593-X | Intestinal Obstruction
on Jul 25, 2007 Female patient from UNITED KINGDOM , 65 years of age, was diagnosed with epilepsy (What is epilepsy?), abdominal discomfort, myocardial infarction, hypercholesterolaemia, pain (What is pain?), cardiac disorder and was treated with Zarontin (View Usage). After Zarontin was administered, patient had the following side effects: intestinal obstruction. Zarontin dosage: . During the same period patient was treated with PHENYTOIN (Freq:bid) (View Phenytoin Review and Phenytoin Label ), OPIOIDS (View Opioids Review and Opioids Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), ATENOLOL (View Atenolol Review and Atenolol Label ).

5382284-9 | Pyrexia, Rash Erythematous
on Jun 28, 2007 Female patient from FRANCE , 14 years of age, was treated with Zarontin (View Usage). Patient experienced the following unwanted or unexpected effects: pyrexia, rash erythematous. Zarontin dosage: . During the same period patient was treated with DEPAKENE (View Depakene Review and Depakene Label ). Patient was hospitalized.

5367912-6 | Venous Thrombosis
Patient was taking Zarontin (View Usage). Patient had the following side effects: venous thrombosis on Jun 11, 2007 from FRANCE Additional patient health information: Female patient , 75 years of age, . Zarontin dosage: . During the same period patient was treated with GARDENALE (View Gardenale Review and Gardenale Label ), LASIX (View Lasix Review and Lasix Label ), TEGRETOL (Text:2 Df) (View Tegretol Review and Tegretol Label ), EPREX (View Eprex Review and Eprex Label ), OMEPRAZOLE (Text:1 Df) (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

5331645-2 | Pyrexia, Rash Erythematous
Adverse event was reported on May 10, 2007 by a Female patient taking Zarontin (View Usage) (Dosage: ) . Location: FRANCE , 14 years of age, After Zarontin was administered, patient had the following side effects: pyrexia, rash erythematous. During the same period patient was treated with DEPAKENE (View Depakene Review and Depakene Label ). Patient was hospitalized.

5328027-6 | Eye Movement Disorder, Malaise, Petit Mal Epilepsy
on May 08, 2007 Male patient from UNITED KINGDOM , 14 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Zarontin (View Usage). Patient experienced the following unwanted or unexpected effects: eye movement disorder, malaise, petit mal epilepsy. Zarontin dosage: . During the same period patient was treated with EPILIM (View Epilim Review and Epilim Label ).

5267714-5 | Petit Mal Epilepsy
on Mar 06, 2007 Male patient from UNITED STATES , weighting 61.73 lb, was diagnosed with petit mal epilepsy and was treated with Zarontin (View Usage). Patient had the following side effects: petit mal epilepsy. Zarontin dosage: .

5261162-X | Petit Mal Epilepsy
Patient was taking Zarontin (View Usage). After Zarontin was administered, patient had the following side effects: petit mal epilepsy on Feb 27, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 61.95 lb, was diagnosed with petit mal epilepsy and. Zarontin dosage: .

5239968-2 | Grand Mal Convulsion
Adverse event was reported on Jan 26, 2007 by a Female patient taking Zarontin (View Usage) (Dosage: ) was diagnosed with epilepsy (What is epilepsy?), hypertension, diabetes mellitus non-insulin-dependent and. Location: NORWAY , 79 years of age, Patient experienced the following unwanted or unexpected effects: grand mal convulsion. During the same period patient was treated with ZARONDAN (View Zarondan Review and Zarondan Label ), COAPROVEL (View Coaprovel Review and Coaprovel Label ), SELO ZOK (View Selo-zok Review and Selo-zok Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ).

5231721-9 | Grand Mal Convulsion
on Jan 25, 2007 Female patient from NORWAY , 79 years of age, was diagnosed with epilepsy (What is epilepsy?), hypertension, diabetes mellitus non-insulin-dependent and was treated with Zarontin (View Usage). Patient had the following side effects: grand mal convulsion. Zarontin dosage: . During the same period patient was treated with ZARONDAN (View Zarondan Review and Zarondan Label ), COAPROVEL (View Coaprovel Review and Coaprovel Label ), SELO ZOK (View Selo-zok Review and Selo-zok Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ).

5229742-5 | Petit Mal Epilepsy
on Jan 24, 2007 Male patient from UNITED STATES , weighting 61.95 lb, was diagnosed with petit mal epilepsy and was treated with Zarontin (View Usage). After Zarontin was administered, patient had the following side effects: petit mal epilepsy. Zarontin dosage: .

5216117-8 | Petit Mal Epilepsy
Patient was taking Zarontin (View Usage). Patient experienced the following unwanted or unexpected effects: petit mal epilepsy on Jan 11, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 61.95 lb, was diagnosed with petit mal epilepsy and. Zarontin dosage: .

5189990-X | Disease Recurrence, Grand Mal Convulsion
Adverse event was reported on Dec 04, 2006 by a Female patient taking Zarontin (View Usage) (Dosage: 250 Mg (250 Mg, 1 In 1 D)) was diagnosed with epilepsy (What is epilepsy?) and. Location: NORWAY , 79 years of age, Patient had the following side effects: disease recurrence, grand mal convulsion. During the same period patient was treated with ZARONDAN (ETHOSUXIMIDE) (View Zarondan (ethosuximide) Review and Zarondan (ethosuximide) Label ), COAPROVEL (HYDROCHLOROTHIAZIDE, IRBESARTAN) (View Coaprovel (hydrochlorothiazide, Irbesartan) Review and Coaprovel (hydrochlorothiazide, Irbesartan) Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ).

5170538-0 | Breast Cancer, Fall, Fracture, Osteoporosis
on Nov 20, 2006 Female patient from UNITED KINGDOM , 59 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Zarontin (View Usage). After Zarontin was administered, patient had the following side effects: breast cancer (What is breast cancer?), fall (What is fall?), fracture (What is fracture?), osteoporosis (What is osteoporosis?). Zarontin dosage: (250 Mg), Oral. During the same period patient was treated with PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), PRIMIDONE (View Primidone Review and Primidone Label ).

5165041-8 | Abdominal Pain Upper, Aggression, Convulsion, Headache, Sedation, Vomiting
on Nov 13, 2006 Female patient from BRAZIL , child 10 years of age, was diagnosed with petit mal epilepsy and was treated with Zarontin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, aggression, convulsion, headache (What is headache?), sedation, vomiting. Zarontin dosage: 750 Mg (250 Mg, 3 In 1 D), Oral. During the same period patient was treated with DEPAKENE (Oral) (View Depakene Review and Depakene Label ), GARDENAL ^AVENTIS^ (PHENOBARBITAL) (View Gardenal ^aventis^ (phenobarbital) Review and Gardenal ^aventis^ (phenobarbital) Label ).

5163895-2 | Complex Partial Seizures, Grand Mal Convulsion, Migraine
Patient was taking Zarontin (View Usage). Patient had the following side effects: complex partial seizures, grand mal convulsion, migraine (What is migraine?) on Nov 13, 2006 from UNITED STATES Additional patient health information: Female patient , 14 years of age, weighting 152.0 lb, was diagnosed with epilepsy (What is epilepsy?), petit mal epilepsy and. Zarontin dosage: 250 Mg (250 Mg, 1 In 1 D), Oral. During the same period patient was treated with PRILOSEC (View Prilosec Review and Prilosec Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), KEPPRA (View Keppra Review and Keppra Label ).

5161080-1 | Convulsion, Photophobia
Adverse event was reported on Nov 07, 2006 by a Female patient taking Zarontin (View Usage) (Dosage: 250 Mg (1 D)) was diagnosed with epilepsy (What is epilepsy?) and. Location: SOUTH AFRICA , 15 years of age, After Zarontin was administered, patient had the following side effects: convulsion, photophobia. During the same period patient was treated with LAMICTAL (View Lamictal Review and Lamictal Label ).

5154634-X | Aggression, Dizziness, Headache, Personality Change, Stereotypy
on Oct 30, 2006 Male patient from UNITED KINGDOM , 24 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Zarontin (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, dizziness (What is dizziness?), headache (What is headache?), personality change, stereotypy. Zarontin dosage: 1500 Mg (750 Mg,2 In 1 D), Oral. During the same period patient was treated with TOPIRAMATE (View Topiramate Review and Topiramate Label ).

5149951-3 | Complex Partial Seizures, Fatigue, Grand Mal Convulsion, Headache, Hearing Impaired, Migraine, Muscle Twitching, Nervousness, Speech Disorder
on Oct 25, 2006 Female patient from UNITED STATES , 14 years of age, weighting 152.0 lb, was diagnosed with epilepsy (What is epilepsy?), petit mal epilepsy and was treated with Zarontin (View Usage). Patient had the following side effects: complex partial seizures, fatigue, grand mal convulsion, headache (What is headache?), hearing impaired, migraine (What is migraine?), muscle twitching, nervousness, speech disorder. Zarontin dosage: 250 Mg (250 Mg, 1 In 1 D), Oral. During the same period patient was treated with PRILOSEC (View Prilosec Review and Prilosec Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), KEPPRA (View Keppra Review and Keppra Label ).

5148103-0 | Arthropathy, Convulsion, Fall, Overweight
Patient was taking Zarontin (View Usage). After Zarontin was administered, patient had the following side effects: arthropathy, convulsion, fall (What is fall?), overweight on Oct 24, 2006 from BRAZIL Additional patient health information: Female patient , weighting 143.3 lb, was diagnosed with epilepsy (What is epilepsy?) and. Zarontin dosage: Oral. During the same period patient was treated with DEPAKENE (View Depakene Review and Depakene Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ). Patient was hospitalized.

5119989-0 | Convulsion
Adverse event was reported on Sep 18, 2006 by a Female patient taking Zarontin (View Usage) (Dosage: 750 Mg (250 Mg, 3 In 1 D), Oral) was diagnosed with convulsion and. Location: BRAZIL , 18 years of age, Patient experienced the following unwanted or unexpected effects: convulsion.

5115403-X | Convulsion
on Sep 11, 2006 Female patient from BRAZIL , 18 years of age, was diagnosed with convulsion and was treated with Zarontin (View Usage). Patient had the following side effects: convulsion. Zarontin dosage: 750 Mg (250 Mg, 3 In 1 D), Oral.

5106327-2 | Breast Cancer Female, Fall, Fracture, Osteoporosis
on Aug 30, 2006 Female patient from UNITED KINGDOM , 59 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Zarontin (View Usage). After Zarontin was administered, patient had the following side effects: breast cancer female, fall (What is fall?), fracture (What is fracture?), osteoporosis (What is osteoporosis?). Zarontin dosage: . During the same period patient was treated with PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), PRIMIDONE (View Primidone Review and Primidone Label ).

5091322-2 | Convulsion, Petit Mal Epilepsy
Patient was taking Zarontin (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, petit mal epilepsy on Aug 14, 2006 from AUSTRALIA Additional patient health information: Male patient , child 5 years of age, weighting 44.09 lb, was diagnosed with convulsion, epilepsy (What is epilepsy?), petit mal epilepsy and. Zarontin dosage: 1000 Mg (500 Mg, 2 In 1 D), Oral. During the same period patient was treated with EPILIM (VALPROATE SODIUM) (View Epilim (valproate Sodium) Review and Epilim (valproate Sodium) Label ).

5053777-9 | Aphasia, Cerebrovascular Accident, Convulsion, Coordination Abnormal, Feeling Abnormal, Malaise, Movement Disorder, Nervousness
Adverse event was reported on Jun 28, 2006 by a Female patient taking Zarontin (View Usage) (Dosage: 250 Mg (250 Mg, 1 In 1 D), Oral) was diagnosed with epilepsy (What is epilepsy?), convulsion and. Location: UNITED KINGDOM , 59 years of age, Patient had the following side effects: aphasia (What is aphasia?), cerebrovascular accident, convulsion, coordination abnormal, feeling abnormal, malaise, movement disorder (What is movement disorder?), nervousness. During the same period patient was treated with ETHOSUXIMIDE (View Ethosuximide Review and Ethosuximide Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ).

5042578-3 | Rash, Somnolence
on Jun 13, 2006 Female patient from FRANCE , child 12 years of age, was diagnosed with ill-defined disorder and was treated with Zarontin (View Usage). After Zarontin was administered, patient had the following side effects: rash (What is rash?), somnolence. Zarontin dosage: 1 Gram (250 Mg, 4 In 1 D), Oral. During the same period patient was treated with TOPIRAMATE (View Topiramate Review and Topiramate Label ), DEPAKENE (View Depakene Review and Depakene Label ). Patient was hospitalized.

5026272-0 | Anxiety, Asthenia, Convulsion, Feeling Abnormal, Headache, Impaired Driving Ability, Memory Impairment, Mood Swings
on May 23, 2006 Female patient from UNITED KINGDOM , 43 years of age, weighting 169.8 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Zarontin (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), asthenia, convulsion, feeling abnormal, headache (What is headache?), impaired driving ability, memory impairment, mood swings. Zarontin dosage: 1750 Mg (250 Mg, 7 In 1 D), Oral; Over 30 Years. During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ), ETHOSUXIMIDE (View Ethosuximide Review and Ethosuximide Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ).

4999983-0 | Condition Aggravated, Convulsion
Patient was taking Zarontin (View Usage). Patient had the following side effects: condition aggravated, convulsion on Mar 27, 2006 from UNITED KINGDOM Additional patient health information: Female patient , child 10 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Zarontin dosage: 9 Ml (4.5 Ml, 2 In 1 D), Oral.

4988278-7 | Activities Of Daily Living Impaired, Condition Aggravated, Convulsion, Petit Mal Epilepsy
Adverse event was reported on Apr 12, 2006 by a Male patient taking Zarontin (View Usage) (Dosage: 1000 Mg (500 Mg, 2 In 1 D), Oral) was diagnosed with convulsion, epilepsy (What is epilepsy?), petit mal epilepsy and. Location: AUSTRALIA , child 5 years of age, weighting 44.09 lb, After Zarontin was administered, patient had the following side effects: activities of daily living impaired, condition aggravated, convulsion, petit mal epilepsy. During the same period patient was treated with EPILIM (VALPROATE SODIUM) (View Epilim (valproate Sodium) Review and Epilim (valproate Sodium) Label ).

4956347-3 | Convulsion
on Mar 16, 2006 Female patient from UNITED KINGDOM , child 10 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Zarontin (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Zarontin dosage: 9 Ml (4.5 Ml, 2 In 1 D), Oral.

4860748-1 | Feeling Abnormal, Grand Mal Convulsion, Headache, Impaired Driving Ability, Memory Impairment, Nervousness, Speech Disorder
on Dec 05, 2005 Female patient from UNITED KINGDOM , 43 years of age, weighting 169.8 lb, was diagnosed with epilepsy (What is epilepsy?), ill-defined disorder and was treated with Zarontin (View Usage). Patient had the following side effects: feeling abnormal, grand mal convulsion, headache (What is headache?), impaired driving ability, memory impairment, nervousness, speech disorder. Zarontin dosage: 1750 Mg (250 Mg, 7 In 1 D), Oral.

4851793-0 | Convulsion, Treatment Noncompliance
Patient was taking Zarontin (View Usage). After Zarontin was administered, patient had the following side effects: convulsion, treatment noncompliance on Nov 28, 2005 from BRAZIL Additional patient health information: Female patient , child 8 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Zarontin dosage: (250 Mg), Oral. During the same period patient was treated with GARDENALE (PHENOBARBITAL SODIUM) (View Gardenale (phenobarbital Sodium) Review and Gardenale (phenobarbital Sodium) Label ).

4776566-9 | Aggression, Confusional State, Delirium, Paranoia, Sexual Activity Increased
Adverse event was reported on Sep 05, 2005 by a Male patient taking Zarontin (View Usage) (Dosage: Oral) was diagnosed with petit mal epilepsy and. Location: FRANCE , 42 years of age, Patient experienced the following unwanted or unexpected effects: aggression, confusional state, delirium, paranoia, sexual activity increased. During the same period patient was treated with DEPAKENE (View Depakene Review and Depakene Label ). Patient was hospitalized.

4751772-8 | White Blood Cell Count Decreased
on Jul 19, 2004 Male patient from UNITED STATES , 45 years of age, weighting 180.0 lb, was diagnosed with convulsion and was treated with Zarontin (View Usage). Patient had the following side effects: white blood cell count decreased. Zarontin dosage: 1250 Mg (2 In 1 D), Oral. During the same period patient was treated with VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ).

4751767-4 | Dehydration, Feeling Abnormal, Grand Mal Convulsion, Hiccups, Influenza, Nasopharyngitis, Petit Mal Epilepsy
on Mar 04, 2005 Male patient from UNITED STATES , 14 years of age, weighting 120.0 lb, was diagnosed with petit mal epilepsy and was treated with Zarontin (View Usage). After Zarontin was administered, patient had the following side effects: dehydration, feeling abnormal, grand mal convulsion, hiccups, influenza, nasopharyngitis, petit mal epilepsy. Zarontin dosage: 750 Mg (250 Mg, 3 In 1 D), Oral. During the same period patient was treated with VITAMINS (View Vitamins Review and Vitamins Label ).

4557005-X | Cerebellar Atrophy
Patient was taking Zarontin (View Usage). Patient experienced the following unwanted or unexpected effects: cerebellar atrophy on Jan 05, 2005 from Additional patient health information: Female patient , 49 years of age, was diagnosed with ill-defined disorder and. Zarontin dosage: 250 Mg, Oral. During the same period patient was treated with PHENOBARBITAL TAB (50 Mg, Oral) (View Phenobarbital Tab Review and Phenobarbital Tab Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ), CLOBAZAM (CLOBAZAM) (View Clobazam (clobazam) Review and Clobazam (clobazam) Label ).